Funder
Deutsche Forschungsgemeinschaft
Reference40 articles.
1. Inflammation in cystic fibrosis lung disease: pathogenesis and therapy;Cantin;J Cyst Fibros Off J Eur Cyst Fibros Soc,2015
2. Inflammation in cystic fibrosis: an update;Roesch;Pediatr. Pulmonol.,2018
3. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;Lancet (London, England),2019
4. Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial;Sutharsan;Lancet Respir. Med.,2022
5. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis;Westhölter;J Cyst Fibros Off J Eur Cyst Fibros Soc. Published online,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献